Longwood, FL (PRWEB) January 27, 2008
Evil has entered the land of Trinivia once again. One nation must rise from ruin and face the growing darkness, while others will succumb to it. New powers rise from the ashes of old; ancient alliances are tested, while old enemies fight once more. For those who oppose evil, there is hope. Unknown to David, a simple craftsman's son, his destiny will collide with this evil. He must embrace his calling despite feelings of inadequacy. Can David and those who support him find the wisdom, faith, and courage to restore a nation, overcome the darkness, and unite a world? An epic story set in a world of castles and palaces, kings and queens, ships and swords, ancient cities and forgotten ruins, R. Michael Love's Return of the Fallen: Legends of Trinivia (paperback, 978-1-60477-133-6; hardcover, 978-1-60477-397-2) will thrill, inspire, and touch the hearts of those who read it.
The book, which is the first in a series, is a powerful Christian story comparable to the great fantasy stories told by the secular world. After reading many fantasy series--such as Lord of the Rings--Love felt called to write one that did not shy away from proclaiming God's goodness. Says the author, "I hope that through a fictional story [readers] can see the truths of God, and that the characters and story will spark an interest in seeking God in their own life."
Born and raised in Florida, Love has been a Christian for 25 years and longs to see people exposed to God's truth. It is his hope that the Legends of Trinivia series will become the greatest epic ever conceived in the Christian market. "The intent is for not just Christians, but all readers to enjoy," he says. "I hope it crosses over the Christian market and can be a vessel for God's glory to the unsaved."
Xulon Press, a part of Salem Communications Corporation, is the world's largest Christian publisher, with more than 4,000 titles published to date. Retailers may order Return of the Fallen through Ingram Book Company and/or Spring Arbor Book Distributors.